The purpose of this study is to determine the effect and safety of Sulodexide in Filipino patients with Chronic Kidney Disease (CKD).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
1,508
SLX 500 LRU, SLX 1000 LRU, SLX 2000 LRU per day to be taken orally for 12 months.
8 soft-gel capsules per day to be taken orally for 12 months
Mary Mediatrix Medical Center
Lipa City, Batangas, Philippines
Rizal Private Clinics
Metro Manila, Rizal, Philippines
Holy Child Hospital
Dumaguete, Philippines
Victoriano R. Potenciano Medical Center
Mandaluyong, Philippines
macroalbuminuria and serum creatinine
Time frame: 52 weeks
adverse events
Time frame: 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Metropolitan Medical Center
Manila, Philippines
Manila Adventist Medical Center
Pasay, Philippines
The Medical City
Pasig, Philippines